Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)
- Status
- COMPLETED
- Phase
- NA
Precision Medicine for Patients With Identified Actionable Mutations
- Status
- TERMINATED
- Phase
- PHASE2
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
- Status
- COMPLETED
- Phase
- NA
Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database
- Status
- UNKNOWN
- Phase
- N/A
A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin
- Status
- UNKNOWN
- Phase
- N/A
Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
- Status
- RECRUITING
- Phase
- N/A
QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease
- Status
- COMPLETED
- Phase
- NA
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
- Status
- UNKNOWN
- Phase
- N/A
Cardiovascular Effects of CART Cell Therapy
- Status
- COMPLETED
- Phase
- N/A
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2